Results 61 to 70 of about 10,230 (170)

A Dose‐Tailored Anti‐Plasma Cell Regimen Lowers the Mortality of Late‐Stage Cardiac Amyloidosis

open access: yesMedComm, Volume 6, Issue 7, July 2025.
The present study was designed to assess the efficacy and safety of a dose‐tailored BD regimen and a dose‐tailored DBD regimen in patients with LCCA at Mayo Stage III. Both the two regimens markedly increased survival rate and time in those patients and the dose‐tailored DBD regimen was superior to the dose‐tailored BD regimen in both efficacy and ...
Yun Ti   +8 more
wiley   +1 more source

Might Be Fabry Disease?

open access: yesTurkish Journal of Internal Medicine, 2020
Fabry disease, also known as Anderson-Fabry disease, is a X-linked lysosomal storage disease. Alpha-galactosidase A (alpha-Gal A) enzyme deficiency leads globotriaosylceramide (Gb3) accumulation in several cells which causes clinical manifestations of ...
Aysegul Oruc
doaj  

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report [PDF]

open access: yes, 2012
Background: Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme α-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids
Albeggiani, G   +7 more
core   +2 more sources

Report of the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) on the effects of climate change on the risk of transmission of foodborne pathogens

open access: yesFood Risk Assess Europe, Volume 3, Issue 3, July 2025.
Abstract The Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) has carried out an updated review of the scientific evidence on the influence of climate change on the transmission of foodborne pathogens. This global phenomenon represents an emerging threat to food safety and public health, since alterations in weather ...
Antonio Valero Díaz   +6 more
wiley   +1 more source

Senza una multidisciplinarietà organizzata

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2017
non disponibile (aiaf)
Roberto Fanelli   +4 more
doaj   +1 more source

A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) [PDF]

open access: yes, 2017
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR).
Ferreira, Vanessa M.   +9 more
core   +2 more sources

Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2034-2046, June 2025.
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman   +9 more
wiley   +1 more source

Free‐Breathing Ungated Radial Simultaneous Multi‐Slice Cardiac T1 Mapping

open access: yesJournal of Magnetic Resonance Imaging, Volume 61, Issue 6, Page 2587-2600, June 2025.
Background Modified Look‐Locker imaging (MOLLI) T1 mapping sequences are acquired during breath‐holding and require ECG gating with consistent R‐R intervals, which is problematic for patients with atrial fibrillation (AF). Consequently, there is a need for a free‐breathing and ungated framework for cardiac T1 mapping.
Johnathan V. Le   +7 more
wiley   +1 more source

Anderson-Fabry′s Disease

open access: yesIndian Journal of Dermatology, 2001
A case of Anderson â€" Fabry’s disease presenting with cutaneous, ophthalmic and cardiological manifestations leading to death at an uncharacteristically early age is reported.
Coondoo Arijit   +2 more
doaj  

Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring

open access: yesOrphanet Journal of Rare Diseases, 2009
Background In Fabry disease (α-galactosidase A deficiency) accumulation of Globotriaosylceramide (Gb3) leads to progressive organ failure and premature death.
Hoffmann Björn
doaj   +1 more source

Home - About - Disclaimer - Privacy